CanaQuest Medical Corp.
CANQF
$0.00
$0.000.00%
OTC PK
| 03/31/2018 | 12/31/2017 | 09/30/2017 | 06/30/2017 | 03/31/2017 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -57.49% | -64.60% | -50.67% | -23.41% | 4.88% |
| Depreciation & Amortization | -8.27% | -17.33% | -4.00% | -15.23% | -13.07% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -42.78% | -59.35% | -48.26% | -18.95% | 4.91% |
| Operating Income | 42.78% | 59.35% | 48.26% | 18.95% | -4.91% |
| Income Before Tax | 55.84% | 60.00% | 18.10% | -11.12% | -37.33% |
| Income Tax Expenses | -- | 200.75% | -- | 101.82% | 101.82% |
| Earnings from Continuing Operations | 55.84% | 59.12% | 18.09% | -11.52% | -37.88% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 55.84% | 59.12% | 18.09% | -11.52% | -37.88% |
| EBIT | 42.78% | 59.35% | 48.26% | 18.95% | -4.91% |
| EBITDA | 43.12% | 59.73% | 48.66% | 19.00% | -5.13% |
| EPS Basic | 67.81% | 71.73% | 36.00% | 9.53% | -14.92% |
| Normalized Basic EPS | 57.20% | 71.69% | 57.53% | 33.17% | 10.64% |
| EPS Diluted | 67.81% | 71.73% | 36.00% | 9.53% | -14.92% |
| Normalized Diluted EPS | 57.20% | 71.69% | 57.53% | 33.17% | 10.64% |
| Average Basic Shares Outstanding | 26.94% | 39.17% | 34.77% | 28.58% | 20.59% |
| Average Diluted Shares Outstanding | 26.94% | 39.17% | 34.77% | 28.58% | 20.59% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |